Refractory

Latest Cancer News

• Dwarfs May Unlock Clues to Cancer (ABC News)
A population of dwarfs is helping researchers find new drugs to prevent cancer.

• Amgen Suspends Trial of Cancer Drug (TheStreet.com)
Enrollment in a late-stage trial of a cancer drug was suspended after patients on the drug died more often than those on placebo.

• Cancer drug Avastin raises risk of blood clots: study (AFP via Yahoo! News)
The anti-cancer drug Avastin increases the risk of blood clots in the legs and lungs by 33 percent, according to an analysis published by US researchers Wednesday.

• Technique Tracks Cancer-Killing Cells (HealthDay via Yahoo! News)
WEDNESDAY, Nov. 19 (HealthDay News) -- U.S. researchers say they've developed a new long-term method of monitoring the location and survival of cancer-killing cells within the body.

• European patent office restores breast cancer gene patent (AFP via Yahoo! News)
The European Patent Office on Wednesday restored on appeal a controversial patent for a breast cancer gene that had been withdrawn from a US biotech firm, but granting it in a more restricted form than before.